May 12, 2026 05:19PM
May 12, 2026 04:01PM
Apr 22, 2026 05:14AM
Apr 22, 2026 12:09AM
Mar 25, 2026 07:47AM
Mar 25, 2026 07:00AM
Mar 25, 2026 07:00AM Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease
Mar 25, 2026 07:00AM
Nov 6, 2025 04:01PM
Nov 6, 2025 07:01AM
Nov 6, 2025 07:00AM
Oct 6, 2025 07:01AM
Oct 6, 2025 07:00AM
Sep 11, 2025 07:35AM Maze Therapeutics raises $150 million in oversubscribed private placement
Sep 11, 2025 07:35AM
Sep 11, 2025 07:30AM
Sep 11, 2025 07:30AM
Sep 2, 2025 07:00AM
Sep 2, 2025 07:00AM
Aug 12, 2025 04:55PM
Aug 12, 2025 04:01PM Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
May 15, 2025 05:23PM
May 14, 2025 04:01PM
Mar 31, 2025 07:30AM
Feb 7, 2025 08:01AM
Feb 7, 2025 08:00AM

1,199,636 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All